LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today launched its innovative arterial femoral cannula, Bi-Flow, designed to prevent limb ischemia ...
MI: Myocardial infarction; TIA: Transient ischemic attack. Adapted with permission from [10]. Alternative access in patients with extensive peripheral vascular disease. Reduction of access site ...
Bi-Flow is first bidirectional femoral arterial cannula validated for 29 days’ use LONDON--(BUSINESS WIRE)-- LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, ...
Femoral cannulae provide greater versatility of cannulation techniques to meet the needs of the changing patient population and the desire for smaller thoracic incisions. Designed to be placed in the ...
SAN DIEGO, CA — Although "rarely selected," ulnar-artery catheterization is comparable, with respect to clinical outcomes, to the more common radial access during PCI, report investigators from the ...
Please provide your email address to receive an email when new articles are posted on . In select patients, common femoral artery stenting appears to be reasonably safe and effective, according to ...
LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its Bi-Flow Extracorporeal Membrane Oxygenation (ECMO) cannula earned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results